PharmTech LCGC Sciex Webinar 11.10
|Articles|June 14, 2010

GC–MS Used to Assess Surgeons' Health Risks

The American Urological Association has used a GC–MS method to determine the health risks faced by surgeons due to toxic by-products in surgical smoke.

The American Urological Association (Linthicum, Maryland) has used a GC–MS method to determine the health risks faced by surgeons due to toxic by-products in surgical smoke. The association has published findings from the Republic of Korea, where scientists looked at smoke produced in prostate vaporisation and transurethral resection.

The team analysed samples from six procedures using GC–MS, looking for potentially harmful chemicals. In their samples, they discovered potential carcinogens, along with chemicals associated with irritation to the skin and eyes and depression of the central nervous system.

Based on these findings, the association is calling for “a higher-quality filter mask, smoke evacuation device, or smoke filter” to be deployed during surgery for the protection of both the operating staff and the patient.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.